Skip to main content
. 2023 Oct 27;10(11):ofad526. doi: 10.1093/ofid/ofad526

Figure 3.

Figure 3.

Meta-analysis estimates of virologic failure (VF) incidence after switch to dolutegravir plus lamivudine in people with human immunodeficiency virus type 1 with historical M184V/I from targeted literature review–identified interventional studies, inclusive of all VF definitions. Abbreviations: CI, confidence interval; PWH, people with human immunodeficiency virus type 1; VF, virologic failure; Wt, weight.